IFM Investors Pty Ltd Boosts Stock Holdings in Kenvue Inc. $KVUE

Key Points

• IFM Investors Pty Ltd increased its stake in Kenvue Inc. by 3.9% during Q2, now holding 373,326 shares valued at approximately $7.81 million.
• Kenvue reported a net margin of 9.37% and a return on equity of 20.06%, despite a 4% decrease in revenue compared to the previous year.
• The company recently raised its quarterly dividend from $0.21 to $0.2075, providing a yield of 4.5%, although its dividend payout ratio is significantly high at 112.16%.

IFM Investors Pty Ltd raised its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 3.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 373,326 shares of the company's stock after buying an additional 13,910 shares during the period. IFM Investors Pty Ltd's holdings in Kenvue were worth $7,814,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in KVUE. Man Group plc bought a new stake in shares of Kenvue in the 4th quarter valued at about $941,000. Waverly Advisors LLC raised its holdings in Kenvue by 79.5% during the 4th quarter. Waverly Advisors LLC now owns 18,536 shares of the company's stock worth $396,000 after purchasing an additional 8,209 shares during the last quarter. Vise Technologies Inc. bought a new position in Kenvue during the 4th quarter worth approximately $242,000. Forum Financial Management LP raised its holdings in Kenvue by 29.2% during the 4th quarter. Forum Financial Management LP now owns 22,917 shares of the company's stock worth $489,000 after purchasing an additional 5,174 shares during the last quarter. Finally, Mackenzie Financial Corp raised its holdings in Kenvue by 12.8% during the 4th quarter. Mackenzie Financial Corp now owns 444,128 shares of the company's stock worth $9,482,000 after purchasing an additional 50,279 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. Evercore ISI lowered their price target on shares of Kenvue from $23.00 to $18.00 and set an "in-line" rating for the company in a report on Tuesday. Royal Bank Of Canada dropped their price objective on Kenvue from $24.00 to $22.00 and set a "sector perform" rating on the stock in a research note on Friday, August 8th. JPMorgan Chase & Co. dropped their price objective on Kenvue from $27.00 to $26.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. Zacks Research raised Kenvue to a "strong sell" rating in a research note on Monday, August 11th. Finally, Citigroup reissued a "neutral" rating on shares of Kenvue in a research note on Tuesday. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $23.63.

Kenvue Stock Performance

Shares of KVUE stock traded up $0.48 during trading on Tuesday, hitting $17.45. The company's stock had a trading volume of 35,807,290 shares, compared to its average volume of 19,075,094. The company has a market cap of $33.48 billion, a PE ratio of 23.59, a P/E/G ratio of 2.63 and a beta of 0.83. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The business has a fifty day moving average of $20.77 and a 200-day moving average of $22.00. Kenvue Inc. has a 52 week low of $16.89 and a 52 week high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.Kenvue's quarterly revenue was down 4.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were issued a $0.2075 dividend. This is a boost from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 annualized dividend and a dividend yield of 4.8%. The ex-dividend date of this dividend was Wednesday, August 13th. Kenvue's dividend payout ratio is currently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.